Michigan Senate Bill SB0600

Michigan 2025-2026 Regular Session

• Introduced: 10/2/25
• Refer: 10/2/25
• Report Pass: 12/2/25
• Refer: 12/2/25
• Report Pass: 12/9/25
• Engrossed: 12/17/25
• Refer: 12/17/25

Caption

Marihuana: other; cross-references to industrial hemp research and development act within the medical marihuana facilities licensing act; amend. Amends title & secs. 102, 206, 502 & 505 of 2016 PA 281 (MCL 333.27102 et seq.). TIE BAR WITH: SB 0599'25

Impact

If enacted, SB 600 would significantly reconfigure the existing legal landscape surrounding medical marihuana in Michigan. It would establish a more structured oversight through the introduction of a statewide monitoring system that manages commercial marihuana transactions. This is aimed at ensuring compliance among all stakeholders, from growers to processors, enhancing safety standards in production, and facilitating better regulatory enforcement. Additionally, the act would provide immunity from prosecution for individuals engaging in activities compliant with its guidelines, which may alleviate legal ambiguities present in current marihuana legislation.

Summary

Senate Bill 600 serves to amend the Medical Marihuana Facilities Licensing Act in Michigan. This legislation focuses on the licensing and regulation of medical marihuana growers, processors, provisioning centers, and safety compliance facilities. Notably, it introduces provisions that allow certain licensees to process, test, or sell industrial hemp, thereby expanding the regulatory framework to include both marihuana and hemp-related activities. Furthermore, the bill proposes the creation of a medical marihuana licensing board and an advisory panel to oversee compliance and facilitate the governance of these facilities.

Sentiment

Discussion around SB 600 has been largely positive, particularly among those who support the expansion of the medical marihuana industry in Michigan. Advocates argue that the bill would not only legitimize and standardize operations within the industry but also ensure the safety of products available to consumers. However, there is some apprehension expressed by certain stakeholders who believe that increased regulations may inadvertently constrain small operators and limit access for patients who rely on medical marihuana.

Contention

The bill has sparked points of contention regarding its implementation and the extent of oversight proposed. Critics caution that any overregulation could stifle the growth of small businesses owned by individuals seeking to enter the marihuana market. They raise concerns that the establishment of stringent compliance requirements and associated costs may create barriers to entry, marginalizing smaller entities in favor of larger, established operations. As the legislative process evolves, these differing perspectives are likely to be pivotal in shaping the final outcomes of SB 600.